How many email patterns does Neuronascent, Inc use?

Neuronascent, Inc uses 1 known email pattern.

What domain does Neuronascent, Inc use for work emails?

Neuronascent, Inc uses neuronascent.com for work email addresses.

Most Common Email Formats at Neuronascent, Inc

The most accurate and popular Neuronascent, Inc's email format is FLast@neuronascent.com (ex. JDoe@neuronascent.com). Neuronascent, Inc also uses as email structures. Neuronascent, Inc uses up to 1 different email patterns.

Neuronascent, Inc Email Formats	Example	Percentage
FLast@neuronascent.com	JDoe@neuronascent.com	100%

Neuronascent, Inc Email Formats

Example

Percentage

FLast@neuronascent.com

JDoe@neuronascent.com

100%

Frequently Asked Questions

What does Neuronascent, Inc do?

Neuronascent, Inc was founded in 2004. The company's main headquarters is located in 6030 Daybreak Circle Clarksville, Maryland 21029 United Statesoperates in the Pharmaceutical Manufacturing industry, along with similar companies like RocheCerevel TherapeuticsAbbVie. You can visit neuronascent.comcontact Neuronascent, Inc's headquarters by phone at

+1-410-258-****

. Explore Neuronascent, Inc's company overview page for more information.

What is Neuronascent, Inc's email address format?

Neuronascent, Inc's email format typically follows the pattern of FLast@neuronascent.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Neuronascent, Inc have currently?

Neuronascent, Inc has approximately 3 employees as of June 2026. Key team members to contact include Member, Board Of Directors: K. N.. For more team information and contact data, explore Neuronascent, Inc's employee directory with LeadIQ.

Neuronascent, Inc Email Format

Pharmaceutical ManufacturingMaryland, United States2-10 Employees

Neuronascent, Inc. is a small biopharmaceutical company based in Clarksville, Maryland, focused on developing disease-modifying therapies for chronic neurodegenerative disorders. Using an internally developed screening approach, it has identified oral small-molecule candidates that can induce the formation of new neurons and support their maturation and function under neurodegenerative conditions, with supporting results in human neuronal cells and animal disease models. Its lead program targets Alzheimer's disease and potentially Parkinson's disease, and early testing indicates the candidate was safe in a first-in-human Phase 1a trial in healthy aged subjects. Additionally, Neuronascent is advancing NNI-351 for fragile X syndrome and related developmental delays. In April 2023, Emer Leahy joined the company's Board of Directors.

Most Common Email Formats at Neuronascent, Inc

Frequently Asked Questions

What does Neuronascent, Inc do?

What is Neuronascent, Inc's email address format?

How many employees does Neuronascent, Inc have currently?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Neuronascent, Inc Email Format

Verify Neuronascent, Inc email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Most Common Email Formats at Neuronascent, Inc

Frequently Asked Questions

What does Neuronascent, Inc do?

What is Neuronascent, Inc's email address format?

How many employees does Neuronascent, Inc have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Neuronascent, Inc Email Format

Verify Neuronascent, Inc email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.